Yes, there are specific Keytruda side effects to watch for. Keytruda, also known as pembrolizumab, is an immunotherapy medication used to treat various types of cancer. Like all medications, Keytruda can cause side effects. According to the drug's official website, some of the most common side effects include fatigue, cough, nausea, itching, rash, and decreased appetite.
However, Keytruda can also cause severe side effects that require immediate medical attention. These severe side effects may occur as the immune system becomes more active, which can affect normal body functions. Some of the severe side effects of Keytruda include:
* Lung problems: cough, chest pain, or shortness of breath [1]
* Intestinal problems: diarrhea, severe stomach pain, or blood in stools [1]
* Liver problems: yellowing of the skin or the whites of the eyes, dark urine, or decreased appetite [1]
* Hormone gland problems: headaches, weight changes, changes in mood or behavior, hair loss, or feeling cold [1]
* Kidney problems: decreased urination, blood in urine, or swelling in ankles [1]
* Skin problems: rash, blistering or peeling skin, or sores in the mouth [1]
* Other symptoms: unusual thoughts or behavior, severe muscle weakness, or vision changes [1]
It is essential to report any side effects to a healthcare professional promptly. Patients should also inform their healthcare provider if they have any other medical conditions or are taking any other medications, as these factors can affect how Keytruda works and increase the risk of side effects.
In addition, it is important to note that Keytruda can have long-term side effects that may not appear until after treatment has ended. These side effects can include thyroid problems, adrenal gland problems, and pituitary gland problems. Patients should continue to monitor their health and report any symptoms to their healthcare provider after treatment has ended.
In summary, Keytruda can cause both common and severe side effects that require medical attention. Patients should be aware of these side effects and report them to their healthcare provider promptly.
Sources:
[1] Keytruda (pembrolizumab) prescribing information. Merck Sharp & Dohme Corp. 2021. Available at: <https://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_pi.pdf>.